Antibiotice SA 2019 Annual Report with Sustainability Disclosures
The report details the financial and operational performance of Antibiotice S.A. for the fiscal year 2019. The company achieved a 7% increase in sales income, reaching 389.7 million LEI, driven by a 25% growth in international sales. Notably, 2019 marked the first year where international sales of finished products outpaced those of the active substance Nystatin. The company continued its expansion in key markets like Vietnam, Moldova, and Serbia, and invested significantly in a new Ointment & Suppository Plant. Additionally, the report highlights the company's commitment to sustainability, environmental protection, and community development through various social responsibility programs.
Company: Antibiotice SA
Sector: Manufacturing
Country: Romania
Year: 2019
Type: Annual Report with Sustainability Disclosures
Pages: 58
Back to company
Antibiotice SA
Management Report
The report details the financial and operational performance of Antibiotice S.A. for the fiscal year 2019. The company achieved a 7% increase in sales income, reaching 389.7 million LEI, driven by a 25% growth in international sales. Notably, 2019 marked the first year where international sales of finished products outpaced those of the active substance Nystatin. The company continued its expansion in key markets like Vietnam, Moldova, and Serbia, and invested significantly in a new Ointment & Suppository Plant. Additionally, the report highlights the company's commitment to sustainability, environmental protection, and community development through various social responsibility programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 2019 - Dec 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees